{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:43:52Z","timestamp":1786992232733,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202140496"],"award-info":[{"award-number":["202140496"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074138"],"award-info":[{"award-number":["82074138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jep.2022.115531","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T10:04:20Z","timestamp":1657879460000},"page":"115531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology"],"prefix":"10.1016","volume":"297","author":[{"given":"Qin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-3992","authenticated-orcid":false,"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jep.2022.115531_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2022.115531_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.jep.2022.115531_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESOURCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jep.2022.115531_bib3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1159\/000484066","article-title":"Luteolin promotes cell apoptosis by inducing autophagy in hepatocellular carcinoma","volume":"43","author":"Cao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.jep.2022.115531_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10585-010-9306-3","article-title":"FAK is involved in invasion and metastasis of hepatocellular carcinoma","volume":"27","author":"Chen","year":"2010","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.jep.2022.115531_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/wics.1310","article-title":"Bioavailability and bioequivalence in drug development","volume":"6","author":"Chow","year":"2014","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"issue":"4","key":"10.1016\/j.jep.2022.115531_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2022.115531_bib7","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jep.2022.115531_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3892\/or.2013.2817","article-title":"Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402\/5-FU cells","volume":"31","author":"Gu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jep.2022.115531_bib9","doi-asserted-by":"crossref","first-page":"D514","DOI":"10.1093\/nar\/gki033","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"33","author":"Hamosh","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jep.2022.115531_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111795","article-title":"Agrimol B present in Agrimonia pilosa Ledeb impedes cell cycle progression of cancer cells through G0 state arrest","volume":"141","author":"Hnit","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2022.115531_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.jep.2022.115531_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41419-020-2413-4","article-title":"miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR","volume":"11","author":"Ji","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jep.2022.115531_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jnutbio.2019.03.018","article-title":"Quercetin inhibits growth of hepatocellular carcinoma by apoptosis induction in part via autophagy stimulation in mice","volume":"69","author":"Ji","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.jep.2022.115531_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The mechanisms of HBV-induced hepatocellular carcinoma","volume":"8","author":"Jiang","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"7869","key":"10.1016\/j.jep.2022.115531_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jep.2022.115531_bib16","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/tox.23316","article-title":"Kaempferol inhibits the cell migration of human hepatocellular carcinoma cells by suppressing MMP-9 and Akt signaling","volume":"36","author":"Ju","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.jep.2022.115531_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/765894","article-title":"Moscatilin inhibits lung cancer cell motility and invasion via suppression of endogenous reactive oxygen species","volume":"2013","author":"Kowitdamrong","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jep.2022.115531_bib18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jep.2022.115531_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nmeth.4083","article-title":"A scored human protein-protein interaction network to catalyze genomic interpretation","volume":"14","author":"Li","year":"2017","journal-title":"Nat. Methods"},{"issue":"23","key":"10.1016\/j.jep.2022.115531_bib20","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.7150\/jca.31287","article-title":"Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma","volume":"10","author":"Liao","year":"2019","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.jep.2022.115531_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3736\/jcim20080201","article-title":"[Cancerous toxin is the key pathogenic factor of malignant tumor]","volume":"6","author":"Ling","year":"2008","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"17","key":"10.1016\/j.jep.2022.115531_bib22","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.7150\/thno.26789","article-title":"Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.jep.2022.115531_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2010.01.004","article-title":"SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration","volume":"37","author":"Long","year":"2010","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.jep.2022.115531_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s12013-021-01008-6","article-title":"Sec62 promotes pro-angiogenesis of hepatocellular carcinoma cells under hypoxia","volume":"79","author":"Meng","year":"2021","journal-title":"Cell Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.jep.2022.115531_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.34172\/apb.2020.058","article-title":"Kaempferol-mediated sensitization enhances chemotherapeutic efficacy of sorafenib against hepatocellular carcinoma: an in silico and in vitro approach","volume":"10","author":"Nair","year":"2020","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"1","key":"10.1016\/j.jep.2022.115531_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2095-4964(14)60006-6","article-title":"Anti-fatty liver effects of oils from Zingiber officinale and Curcuma longa on ethanol-induced fatty liver in rats","volume":"12","author":"Nwozo","year":"2014","journal-title":"J. Integr. Med."},{"issue":"4","key":"10.1016\/j.jep.2022.115531_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042163","article-title":"Association of adipose tissue and adipokines with development of obesity-induced liver cancer","volume":"22","author":"Rajesh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jep.2022.115531_bib28","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3892\/ijo.2017.3886","article-title":"Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells","volume":"50","author":"Ren","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"23","key":"10.1016\/j.jep.2022.115531_bib29","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.7150\/jca.48100","article-title":"NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt\/betacatenin pathway","volume":"11","author":"Ren","year":"2020","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.jep.2022.115531_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-020-2558-1","article-title":"Differential effectiveness of tyrosine kinase inhibitors in 2D\/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells","volume":"11","author":"Rodriguez-Hernandez","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jep.2022.115531_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jep.2022.115531_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116933","article-title":"Beyond its antioxidant properties: quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats","volume":"236","author":"Salama","year":"2019","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.jep.2022.115531_bib33","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.jep.2022.115531_bib34","doi-asserted-by":"crossref","first-page":"D556","DOI":"10.1093\/nar\/gki122","article-title":"GeneTide--Terra Incognita Discovery Endeavor: a new transcriptome focused member of the GeneCards\/GeneNote suite of databases","volume":"33","author":"Shklar","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jep.2022.115531_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jep.2015.03.065","article-title":"Antitumor immunostimulatory activity of polysaccharides from Salvia chinensis Benth","volume":"168","author":"Shu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2022.115531_bib36","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets","volume":"34","author":"Stark","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.jep.2022.115531_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111639","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jep.2022.115531_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","article-title":"Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease","volume":"145","author":"Tao","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.jep.2022.115531_bib39","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1078-0432.CCR-12-0151","article-title":"Second-line therapies in hepatocellular carcinoma: emergence of resistance to sorafenib","volume":"18","author":"Villanueva","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.jep.2022.115531_bib40","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"issue":"62","key":"10.1016\/j.jep.2022.115531_bib41","doi-asserted-by":"crossref","first-page":"105848","DOI":"10.18632\/oncotarget.22406","article-title":"Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.jep.2022.115531_bib42","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/bph.15360","article-title":"Molecular mechanism and pharmacokinetics of flavonoids in the treatment of resistant EGF receptor-mutated non-small-cell lung cancer: a narrative review","volume":"178","author":"Wang","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.jep.2022.115531_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101993","article-title":"Quercetin inhibits the proliferation of glycolysis-addicted HCC cells by reducing hexokinase 2 and akt-mTOR pathway","volume":"24","author":"Wu","year":"2019","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.jep.2022.115531_bib44","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1002\/cam4.2388","article-title":"Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2\/STAT3 signaling pathway","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.jep.2022.115531_bib45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3724\/SP.J.1008.2011.00749","article-title":"Anti-tumor constituents from the roots of <I>Actinidia valvata<\/I&gt","volume":"31","author":"Xu","year":"2011","journal-title":"Acad. J. Second Mil. Med. Univ."},{"key":"10.1016\/j.jep.2022.115531_bib46","first-page":"1292","article-title":"In vitro effect of Actinidia valvata Dunn injection on two kinds of hepatoma cells and normal hepatocytes","volume":"42","author":"Xubo Shen","year":"2015","journal-title":"Liaoning J. Tradit. Chin. Med."},{"key":"10.1016\/j.jep.2022.115531_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phymed.2018.10.027","article-title":"MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1","volume":"57","author":"Yang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2022.115531_bib48","first-page":"918","article-title":"The inhibitory effect and mechanism of effective parts of Actinidia valvata Dunn on transplanted tumor H22 in mice","volume":"31","author":"Yani Zhang","year":"2006","journal-title":"China J. Chin. Mater. Med."},{"issue":"7","key":"10.1016\/j.jep.2022.115531_bib49","first-page":"842","article-title":"In fluence of Sanshimao prescription on the recurrence of tumor after liver cancer resection in athymic mice and its mechanism","volume":"39","author":"Yongbin Meng","year":"2019","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"issue":"2","key":"10.1016\/j.jep.2022.115531_bib50","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3892\/ol.2014.2766","article-title":"Herbal medicine Guan Chang Fu Fang enhances 5-fluorouracil cytotoxicity and affects drug-associated genes in human colorectal carcinoma cells","volume":"9","author":"Yu","year":"2015","journal-title":"Oncol. Lett."},{"issue":"10","key":"10.1016\/j.jep.2022.115531_bib51","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/cncr.30915","article-title":"Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: a randomized controlled study","volume":"124","author":"Zhai","year":"2018","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.jep.2022.115531_bib52","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/jgh.13425","article-title":"Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib","volume":"31","author":"Zhang","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2022.115531_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.jep.2022.115531_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2095-4964(14)60039-X","article-title":"Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities","volume":"12","author":"Zhao","year":"2014","journal-title":"J. Integr. Med."},{"issue":"1","key":"10.1016\/j.jep.2022.115531_bib55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122005700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122005700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:26:03Z","timestamp":1759944363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874122005700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":56,"alternative-id":["S0378874122005700"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2022.115531","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2022.115531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115531"}}